Ligand validation:6XXI

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XXI_MRD_B_1509	76%	58%	0.107	0.943	0.62	0.95	-	1	0	0	100%	0.92
8A0G_MRD_A_402	56%	55%	0.144	0.916	0.63	1.07	-	1	0	0	100%	0.86
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
4YZA_MRD_A_208	97%	59%	0.056	0.972	0.37	1.15	-	1	0	0	100%	0.91
4MKN_MRD_A_306	96%	67%	0.068	0.98	0.4	0.85	-	-	0	0	100%	0.5
3GZB_MRD_G_156	96%	69%	0.066	0.973	0.43	0.73	-	-	0	0	100%	1
4IIC_MRD_A_940	95%	54%	0.064	0.966	1.33	0.48	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.